
Full profile: /officials/C001088
Source: Congress.gov · FEC
Members who have signed on to support this bill since introduction. Source: Congress.gov.
The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →
Read twice and referred to the Committee on Commerce, Science, and Transportation.
2025-11-18
Source: Congress.gov
Previously
This bill aims to strengthen the U.S. biomanufacturing industry—the production of medicines, vaccines, and biological products—by investing in research, workforce training, and manufacturing facilities. It would help American companies compete globally in biotechnology while reducing dependence on other countries for critical medicines and vaccines. The legislation affects pharmaceutical companies, research institutions, workers entering the biotech field, and patients who depend on these medicines.
AI-assisted summary generated from the official bill metadata (title, subjects, actions) sourced from Congress.gov. Cached and reviewed. Always verify against the official text linked below.
Bills by the same sponsor or covering overlapping subjects.